Predictive model of IVF outcomes for polycystic ovarian morphology and polycystic ovary syndrome in GnRH antagonist protocol using AMH ‐ MoM and ovarian sensitivity index

Documenti analoghi

• GnRH agonists stop antagonist protocol versus GnRH antagonist protocol in poor ovarian responders undergoing IVF
  di: Atefeh Khezri
  Pubblicazione: (2022)
• Role of the mitophagy‐apoptosis axis in the pathogenesis of polycystic ovarian syndrome
  di: Hiroshi Kobayashi, et al.
  Pubblicazione: (2024)
• The impact of the trigger day progesterone, luteinizing hormone and their interaction on live birth rates in GnRH antagonist cycles
  di: Onur Ince, et al.
  Pubblicazione: (2025)
• Metformin enhances the survival ability of ovarian granulosa cells in polycystic ovary syndrome by promoting LINC00548 to suppress androgen receptor/klotho pathway
  di: Guangxin Pan, et al.
  Pubblicazione: (2024)
• The impact of androgens on pregnancy and fetal outcomes in patients with polycystic ovary syndrome
  di: Ömer Tammo, et al.
  Pubblicazione: (2025)